Stockscreener 앱 받기
164.65
1.25%
2.04
시간 외 거래:
164.65
전일 마감가:
$162.61
열려 있는:
$163.15
하루 거래량:
1.28M
Relative Volume:
0.56
시가총액:
$27.64B
수익:
$15.50B
순이익/손실:
$1.33B
주가수익비율:
22.43
EPS:
7.34
순현금흐름:
$2.16B
1주 성능:
+3.74%
1개월 성능:
+18.37%
6개월 성능:
-15.62%
1년 성능:
-20.64%
1일 변동 폭
$161.72
$164.91
1주일 범위
$155.15
$167.32
52주 변동 폭
$134.65
$252.88
아이큐비아 홀딩스 Stock (IQV) Company Profile
명칭
Iqvia Holdings Inc
전화
919-998-2000
주소
2400 ELLIS ROAD, DURHAM, NC
IQV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
164.65 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
427.76 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.50 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
542.71 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.66 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
아이큐비아 홀딩스 Stock (IQV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-25 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-20 | 개시 | Stephens | Overweight |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2024-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-13 | 개시 | BTIG Research | Buy |
| 2023-11-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-03-17 | 개시 | Truist | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-11-17 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-16 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2020-07-07 | 개시 | Stephens | Equal-Weight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-12-13 | 업그레이드 | CFRA | Sell → Hold |
| 2019-11-14 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | 업그레이드 | Mizuho | Neutral → Buy |
| 2019-05-28 | 개시 | SVB Leerink | Outperform |
| 2019-01-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-10-09 | 개시 | UBS | Buy |
| 2018-10-02 | 재확인 | Robert W. Baird | Outperform |
| 2018-07-25 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 재확인 | Stifel | Buy |
| 2018-07-03 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-03-07 | 업그레이드 | SunTrust | Hold → Buy |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
모두보기
아이큐비아 홀딩스 주식(IQV)의 최신 뉴스
Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating - MarketScreener
Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) - Yahoo Finance
IQVIA Holdings Stock: Is IQV Underperforming the Healthcare Sector? - MSN
IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’ - Business Wire
Learn to Evaluate (IQV) using the Charts - news.stocktradersdaily.com
Park Avenue Securities LLC Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA Completes $2 Billion Senior Notes Offering - Global Legal Chronicle
Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - Benzinga
IQVIA unveils AI agents for life sciences using NVIDIA technology By Investing.com - Investing.com South Africa
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQVIA Launches New AI Agents for Life Sciences and Healthcare - MarketScreener
IQVIA unveils AI agents for life sciences using NVIDIA technology - Investing.com
IQVIA Holdings Stock: Is IQV Underperforming The Healthcare Sector? - Barchart.com
IQVIA Stock: Stuck In A Time SpiralValue Play Or Bull Trap? - Benzinga
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week - Yahoo Finance
IQVIA Holdings Inc (IQV) Trading 3.9% Higher on Jun 10 - GuruFocus
IQVIA Holdings (IQV) Leads S&P 500 Healthcare Gainers - GuruFocus
IQVIA Holdings Issues $2 Billion in Senior Notes - TipRanks
IQVIA Holdings Inc (IQV) Trading 3.85% Higher on Jun 4 - GuruFocus
IQVIA to raise $2B via senior notes offering to repay debt - MSN
IQVIA announces pricing of senior notes - MSN
IQVIA prices $2 billion senior notes offering By Investing.com - Investing.com South Africa
IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offe - GuruFocus
Rep. Robert Bresnahan, Jr. Sells Off Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA Announces Pricing of Senior Notes - 01net
IQVIA Inc. (IQV) Secures $2 Billion in Senior Notes Offering - GuruFocus
IQVIA Holdings Announces $2 Billion Senior Notes Offering - TipRanks
IQVIA Announces Pricing of Senior Notes | IQV Stock News - GuruFocus
IQVIA Prices $2 Billion Senior Notes Due 2032 - marketscreener.com
IQVIA Announces Pricing Of Senior Notes - marketscreener.com
IQVIA prices $2 billion senior notes offering - Investing.com Australia
IQVIA announces offering of senior notes - IQVIA
IQVIA Announces Offering of Senior Notes - BioSpace
Iqvia Plans $2 Billion Notes Offering - marketscreener.com
IQVIA Announces Offering of Senior Notes | IQV Stock News - GuruFocus
IQVIA plans $2 billion senior notes offering by 2032 - Investing.com
Iqvia Announces Offering Of Senior Notes - marketscreener.com
IQVIA Holdings Inc. (NYSE:IQV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
What is Zacks Research’s Forecast for IQVIA Q2 Earnings? - Defense World
IQVIA Holdings Inc (IQV) Trading 3.28% Higher on May 27 - GuruFocus
IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com
IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus
IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV Stock News - GuruFocus
Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com
아이큐비아 홀딩스 (IQV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이큐비아 홀딩스 주식 (IQV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DANHAKL JOHN G | Director |
Dec 03 '24 |
Buy |
200.58 |
1,275 |
255,740 |
1,275 |
| Sherbet Eric | See Remarks |
Aug 27 '24 |
Sale |
246.33 |
1,300 |
320,229 |
19,536 |
0.03%
1.61%
자본화:
|
볼륨(24시간):